Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review

Clinical and Laboratory Haematology

Volumn 18, Issue 4, 1996, Pages 291-295

  Hill, G R ^a   Hickton, C M ^a   Brennan, S O ^a   Atkinson, C H ^a   Heaton, D C ^a,b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b NONE   (New Zealand)

Author keywords

Antithrombins; Breast carcinoma; Heparin like anticoagulants

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; HEPARINOID;

ADULT; ARTICLE; BREAST CARCINOMA; CASE REPORT; FEMALE; HUMAN; METASTASIS; PRIORITY JOURNAL;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS; BREAST NEOPLASMS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPARIN; HEPARITIN SULFATE; HUMANS; MIDDLE AGED; THROMBIN TIME;

EID: 0030483538     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barthels M. & Heimburger N. (1985) Acquired thrombin inhibitor in a patient with liver cirrhosis. Haemostasis 15, 395-401.
2. Berrettini M. & Nenci G.G. (1984) Circulating heparin-like anticoagulants (letter). New England Journal of Medicine 311, 1055.
3. Bussel J.B., Steinherz P.G., Miller D.R. & Hilgartner M.W. (1984) A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukaemia. American Journal of Hematology 16, 83-90.
4. Chapman G.S., George C.B. & Danley D.L. (1985) Heparin-like anticoagulant associated with plasma cell myeloma. American Journal of Clinical Pathology 83, 764-766.
5. Costa J.M., Fiessinger J.N., Capron L. & Aiach M. (1992) Partial characterization of an autoantibody recognizing the secondary binding site (s) of thrombin in a patient with recurrent spontaneous arterial thrombosis. Thrombosis and Haemostasis 67, 193-199.
6. de Prost D., Katlama C., Pialoux G., Karsenty-Mathonnet F. & Wolff M. (1987) Heparin-like anticoagulant associated with AIDS. Thrombosis and Haemostasis 57, 239.
7. Gabriel D.A., Carr M.E., Cook L. & Roberts H.R. (1987) Spontaneous antithrombin in a patient with benign paraprotein. American Journal of Hematology 25, 85-93.
8. Garnier G., Taillan B., Castanet J., Pesce A. & Dujardin P. (1991) [Heparin-like anticoagulant in small cell bronchial carcinoma]. Revue de Medecine interne 12, 213-214.
9. Horne M.K., Chao E.S., Wilson O.J., Scialla S.J., Lynch M.A. & Kragel P.J. (1991) A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma. Journal of Laboratory and Clinical Medicine 118, 250-260.
10. Horne M.K, Stein C.A., LaRocca R.V. & Myers C.E. (1988) Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 71, 273-279.
11. Kaufman P.A., Gockerman J.P. & Greenberg C.S. (1989) Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature. The American Journal of Medicine 86, 612-616,
12. Khoory M.S., Nesheim M.E., Bowie E.J.W. & Mann K.G. (1980) Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. Journal of Clinical Investigation 65, 666-674.
13. La Spada A.R., Skalhegg B.S., Henderson R., Schmer G., Pierce R. & Chandler W. (1995) Brief report: fatal hemorrhage in a patient with an acquired inhibitor of human thrombin. The New England Journal of Medicine 333, 494-497.
14. Laurie G.W., Leblond C.P. & Martin G.R. (1982) Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes. The Journal of Cell Biology 95, 340-344.
15. Liebam H.A., Comenzo R., Allen S.T. & Dilorio J.M. (1991) A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer. American Journal of Hematology 38, 24-29.
16. Lindblom A., Carlstedt I. & Fransson L. (1989) Identification of the core proteins in proteoglycans synthesized by vascular endothelial cells. Biochemical Journal 261, 145-153.
17. Marcum J.A., Atha D.H., Fritze L.M.S., Nawroth P., Stern D. & Rosenberg R.D. (1986) Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. The Journal of Biological Chemistry 261, 7507-7517.
18. Oohira A., Wight T.N. & Bornstein P. (1983) Sulfated proteoglycans synthesized by vascular endothelial cells in culture. The Journal of Biological Chemistry 258, 2014-2021.
19. Palmer R.N., Rick M.E., Rick P.D., Zeller J.A. & Gralnick H.R. (1984) Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. The New England Journal of Medicine 310, 1696-1699.
20. Rodgers G.M. & Corash L. (1985) Acquired heparinlike anticoagulant in a patient with metastatic breast carcinoma. The Western Journal of Medicine 143, 673-675.
21. Scully M.F., Ellis V., Kakkar V.V., Savidge G.F., Williams Y.F. & Sterndale H. (1982) An acquired coagulation inhibitor to factor II. British Journal of Haematology 50,655-664.
22. Sie P., Bezeaud A., Dupouy D. et al. (1991) An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme. Journal of Clinical Investigation 88, 290-296.
23. Shojania A.M., Meilleur G. & Alvi A.W. (1987) An autoantibody with potent antithrombin activity whose action could be inhibited by toluidine blue or methylene blue. American Journal of Hematology 24, 207-214.
24. Stricker R.B., Lane P.K., Leffert J.D., Rodgers G.M., Shuman M.A. & Corash L. (1988) Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood 72, 1375-1380.
25. Teien A.N., Abildgaard U. & Hook M. (1976) The anticoagulant effect of heparan sulfate and dermatan sulfate. Thrombosis Research 8, 859.
26. Tefferi A., Owen B.A., Nicholas W.L., Witzig T.E. & Owen W.G. (1989) Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma. Blood 74, 252-254.
27. Watts E., Chisholm M., Hicton M. & Smith A.G. (1984) Circulating heparin-like anticoagulants (letter) New England Journal of Medicine 311, 1055.